Skip to content

13F-HR filed by GILEAD SCIENCES, INC.

GILEAD SCIENCES, INC. filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 9 holding rows worth $1,791,467,184.

Accession
0001123292-25-000642
Filed
2025-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 9 entries on the cover page, a total value of $1,791,467,184 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,791,467,184 with VALUE read as dollars as filed, 13F file number 028-25078. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR16,707,477$578,747,003dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock6,720,803$551,777,926dollars as filed
ARCUS BIOSCIENCES INC03969F109COM31,424,760$427,376,736dollars as filed
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK4,505,391$115,338,010dollars as filed
MERUS N VN5749R100COM452,527$42,605,417dollars as filed
TANGO THERAPEUTICS INC87583X109COM4,854,443$40,777,321dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK4,126,119$24,756,714dollars as filed
Xilio Therapeutics Inc.98422T100COM9,105,451$7,673,164dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW5,319,148$2,414,893dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001123292-25-000642this filing2025-11-13acceptance time not in the bulk data set